Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00349583 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00349583: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00349583 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00349583, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to evaluate the efficacy on quality of vision and dry eye signs and symptoms in patients undergoing cataract surgery using the ReZoom® multifocal IOL.
Interventions
- DRUG Topical Cyclosporine, Tears
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00349583 record still lists
NCT00349583 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Topical Cyclosporine, Tears is the first listed.
NCT00349583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00349583 about?
NCT00349583 is a clinical study titled "Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation". The purpose of this study is to evaluate the efficacy on quality of vision and dry eye signs and symptoms in patients undergoing cataract surgery using the ReZoom® multifocal IOL.
What is the current status of trial NCT00349583?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00349583?
The interventions under investigation include: Topical Cyclosporine, Tears (DRUG).
Who is sponsoring clinical trial NCT00349583?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.